XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 242,274 $ 258,400 $ 482,000 $ 493,892
Cost of products sold 167,531 158,424 318,227 307,266
Gross profit 74,743 99,976 163,773 186,626
Selling expenses 26,926 26,867 54,696 51,848
General and administrative expenses 23,363 25,709 49,810 53,152
Research and development expenses 6,102 6,541 12,268 12,442
Amortization of intangibles 7,547 7,508 15,047 14,385
Operating expenses 63,938 66,625 131,821 131,827
Income from operations 10,805 33,351 31,952 54,799
Interest and debt expense 8,352 10,211 16,587 18,836
Investment (income) loss (610) 88 (819) (454)
Foreign currency exchange (gain) loss (792) 1,746 (398) 2,230
Other (income) expense, net 23,806 393 24,484 605
Income (loss) before income tax expense (benefit) (19,951) 20,913 (7,902) 33,582
Income tax expense (benefit) (4,908) 5,100 (1,488) 8,494
Net income (loss) $ (15,043) $ 15,813 $ (6,414) $ 25,088
Average basic shares outstanding (in shares) 28,869 28,725 28,852 28,694
Average diluted shares outstanding (in shares) 28,869 29,001 28,852 28,962
Basic income (loss) per share (in dollars per share) $ (0.52) $ 0.55 $ (0.22) $ 0.87
Diluted income (loss) per share (in dollars per share) (0.52) 0.55 (0.22) 0.87
Dividends declared per common share (in dollars per share) $ 0.07 $ 0.07 $ 0.07 $ 0.07